National action plan to combat multidrug-resistant tuberculosis
- PMID: 1640920
National action plan to combat multidrug-resistant tuberculosis
Abstract
At no time in recent history has tuberculosis (TB) been as great a concern as it is today. TB cases are on the increase, and the most serious aspect of the problem is the recent occurrence of outbreaks of multidrug-resistant (MDR) TB, which pose an urgent public health problem and require rapid intervention. A Task Force composed of representatives of many federal agencies has developed a National Action Plan for addressing this problem. The Task Force identified a number of objectives to be met if MDR-TB is to be successfully combatted. These objectives fall under the categories of a) surveillance and epidemiology--determining the magnitude and nature of the problem; b) laboratory diagnosis--improving the rapidity, sensitivity, and reliability of diagnostic methods for MDR-TB; c) patient management--effectively managing patients who have MDR-TB and preventing patients with drug-susceptible TB from developing drug-resistant disease; d) screening and preventive therapy--identifying persons who are infected with or at risk of developing MDR-TB and preventing them from developing clinically active TB; e) infection control--minimizing the risk of transmission of MDR-TB to patients, workers, and others in institutional settings; f) outbreak control; g) program evaluation--ensuring that TB programs are effective in managing patients and preventing MDR-TB; h) information dissemination/training and education; and i) research to provide new, more effective tools with which to combat MDR-TB. The Action Plan lays out a series of activities to be undertaken at the national level. For each category, the Plan presents statements of problems to be overcome, followed by a summary of the objective to be achieved and steps to be carried out. For each implementation step, responsibility is assigned to the appropriate organization and start-up dates are listed.
Similar articles
-
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43. MMWR Recomm Rep. 2009. PMID: 19214162
-
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.Public Health Rep. 1992 Nov-Dec;107(6):616-25. Public Health Rep. 1992. PMID: 1454973 Free PMC article.
-
The epidemiology of multidrug-resistant tuberculosis in the United States.Med Clin North Am. 1993 Nov;77(6):1391-409. doi: 10.1016/s0025-7125(16)30200-0. Med Clin North Am. 1993. PMID: 8231419 Review.
-
HIV infection and multidrug-resistant tuberculosis: the perfect storm.J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. doi: 10.1086/518665. J Infect Dis. 2007. PMID: 17624830 Review.
-
Meeting the challenge of multidrug-resistant tuberculosis: summary of a conference.MMWR Recomm Rep. 1992 Jun 19;41(RR-11):51-7. MMWR Recomm Rep. 1992. PMID: 1322487
Cited by
-
European policies on tuberculosis prevention in healthcare workers: Which role for BCG? A systematic review.Hum Vaccin Immunother. 2016 Nov;12(11):2753-2764. doi: 10.1080/21645515.2016.1200776. Epub 2016 Jul 7. Hum Vaccin Immunother. 2016. PMID: 27388449 Free PMC article.
-
Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.J Clin Microbiol. 2012 Apr;50(4):1233-9. doi: 10.1128/JCM.06479-11. Epub 2012 Feb 1. J Clin Microbiol. 2012. PMID: 22301024 Free PMC article.
-
The scourge of tuberculosis revisited.Can J Infect Dis. 1995 Nov;6(6):296-7. doi: 10.1155/1995/130795. Can J Infect Dis. 1995. PMID: 22550408 Free PMC article. No abstract available.
-
Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough.Int J Tuberc Lung Dis. 2012 Oct;16(10):1331-4. doi: 10.5588/ijtld.11.0812. Epub 2012 Aug 3. Int J Tuberc Lung Dis. 2012. PMID: 22863311 Free PMC article.
-
Polymerase chain reaction in the diagnosis of tuberculosis.Indian J Clin Biochem. 2000 Aug;15(Suppl 1):200-16. doi: 10.1007/BF02867559. Indian J Clin Biochem. 2000. PMID: 23105283 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous